Showing results (191-200 of 241) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)Janos L Tanyi, Leslie M Randall, Setsuko K Chambers, et al.
British Journal of Cancer|November 8, 2017
Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancerStephanie Markovina, Songyan Wang, Lauren E Henke, et al.
Gynecologic Oncology|April 18, 2013
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancerIsrael Zighelboim, Jason D Wright, Feng Gao, et al.
Gynecologic Oncology|September 8, 2018
SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growthKathryn A Mills, S Tanner Roach, Jeanne M Quinn, et al.
Gynecologic Oncology|May 29, 2018
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancerCarol Aghajanian, Virginia Filiaci, Don S Dizon, et al.
Gynecologic Oncology|November 13, 2025
Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinomaRachel L Furuya, Whitney Grither, Mark G Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology TrialMatthew A Powell, Virginia L Filiaci, Martee L Hensley, et al.
Gynecologic Oncology|August 27, 2023
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Cancers|December 10, 2021
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous CancerMichael D Toboni, Elena Lomonosova, Shaina F Bruce, et al.
Gynecologic Oncology|December 7, 2002
Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapyJeanne M Schilder, Amy M Thompson, Paul D DePriest, et al.
Pageof 25